Halberstadt, AL; Klein, LM; Chatha, M; Valenzuela, LB; Stratford, A; Wallach, J; Nichols, DE; Brandt, SD. Pharmacological characterization of the LSD analog N-ethyl-N-cyclopropyl lysergamide (ECPLA). Psychopharmacology, 8 Oct 2018, 236 (2), 799-808. 526 kB. https://doi.org/10.1007/s00213-018-5055-9 #ECPLA
Wagmann, L; Richter, LHJ; Kehl, T; Wack, F; Bergstrand, MP; Brandt, SD; Stratford, A; Maurer, HH; Meyer, MR. In vitro metabolic fate of nine LSD-based new psychoactive substances and their analytical detectability in different urinary screening procedures. Anal. Bioanal. Chem., 1 Jul 2019, 411 (19), 4751-4763. 3.8 MB. https://doi.org/10.1007/s00216-018-1558-9 #34 MS
Brandt, SD; Kavanagh, PV; Westphal, F; Stratford, A; Elliott, SP; Dowling, G; Halberstadt, AL. Analytical profile of N-ethyl-N-cyclopropyl lysergamide (ECPLA), an isomer of lysergic acid 2,4-dimethylazetidide (LSZ). Drug Test. Anal., 16 Aug 2020, 12 (1), 1514-1521. 7.7 MB. https://doi.org/10.1002/dta.2911 #ECPLA MS,NMR,IR,UV
N-Piperidine lysergamide · LA-Pip · LSD-Pip
MPD-75 · Pyrrolidine 1-methyllysergamide